In the Special Content Considerations section of the AMCP Format for Formulary Dossiers, the third topic is Companion Diagnostic Tests. There are many ways to define companion diagnostic tests (CDTs), and manufacturers may or may not have a relationship with the CDTs associated with their product, which can affect how they proceed with their dossier.

Check back for more information on changes in the new AMCP Format for Formulary Submissions. If you need any assistance with your dossier, let us know: 877-477-0977 or https://medcommunications.com/contact-us/

#AMCP #dossierwriting #managedcare